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Abstract 
Objectives: Breast cancer enhances anxiety and depressive vulnerability, profoundly 
impairing the quality of life in survivors. Hinging on recent research that training attentional 
control can reduce emotional vulnerability, we assess how improving cognitive function 
could reduce emotional vulnerability in female survivors of breast cancer.  
Methods: Participants took part in a course of adaptive dual n-back cognitive training 
(Training Group) or a non-adaptive active control group (Active Control) for 12 days across a 
two-week period. Transfer-related training gains were assessed immediately after the 
intervention, at a shorter one-month follow-up and at a longer follow-up time of 
approximately 15 months post intervention, to assess sustainability of training effects. 
Results: Adaptive cognitive training reduced anxiety and rumination with effects evident at 
shorter and longer term follow-up assessments.  
Conclusions:  Our results are amongst the first to suggest that adaptive cognitive training can 
reduce emotional vulnerability in breast cancer, with the potential to enhance quality of life in 
survivorship. Our findings have profound implications for designing interventions targeting 
cognitive function in populations who’ve suffered from cancer.  
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Introduction 
Breast Cancer is the biggest cause of malignancy in women worldwide [1]. While 
medical advancements can help extend survival to 10 or more years post diagnosis [2], the 
psychological cost of diagnosis and treatment has shown to profoundly enhance vulnerability 
to anxiety and depression, psychological distress, rumination, and post-traumatic stress, 
greatly impairing quality of life [3]. Indeed, around 60% of patients with a breast cancer 
diagnosis still suffer from post-traumatic stress symptoms at one-year post diagnosis [4]. Fear 
of recurrence, anxieties regarding mortality, altered body image following surgery, changes 
in sexuality and fears regarding the impact of diagnoses on immediate families can impact 
societal commitments, relationships and personal and familial well-being [see, 5, for a 
review]. For younger breast cancer sufferers there is also loss of fertility and early menopause 
as a result of treatment-induced hormonal changes from chemotherapy [6].  
 Corroborating behavioral studies, recent neural findings investigating the effects of 
chemotherapy have established structural and functional changes within the central nervous 
system, associated with the specific cognitive impairments that breast cancer survivors 
describe, most notably functions of verbal working memory, attention and executive 
functions [see, 7, for a review]. Aromatase inhibitors and selective estrogen receptor 
modulators such as tamoxifen used in endocrine therapy can also contribute to cognitive 
decline, both alone and in combination with chemotherapy [8]. Such cognitive deficits are 
even found prior to adjuvant therapy, shortly after diagnosis, suggesting that the trauma 
associated with diagnosis can severely impact cognitive function [9].  
The instrumental role of cognitive health in emotional well-being is substantiated in 
recent interventions that target cognitive function to improve well-being in anxiety and 
depression [10]. Based on recent theoretical breakthroughs in cognitive and clinical 
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neuroscience advocating a causal role for attentional control in the onset, maintenance, and 
recurrence of anxiety and depressive vulnerability, increasing evidence shows that training 
cognitive control can reduce and protect against anxiety and depressive vulnerability [11- 
14]. Attentional control is the ability to exercise and regulate attention towards relevant and 
away from irrelevant information, flexibly and efficiently [15], playing a vital role in 
everyday and complex activities. Growing evidence supports predictions from Attentional 
Control Theory [15] that top down attention necessary for goal achievement is disrupted by 
excessive negative affect reducing processing efficiency [16, 17].  
Research on reducing emotional vulnerability through the exercise of attentional 
control using engaging computerized cognitive tasks is growing in clinical research [see, 18 
for a review]. Such techniques can target key neural circuits enabling transfer related benefits 
to a number of related cognitive capabilities [19]. Critically, transfer effects are found on 
enhanced executive functioning [20] and long term improvement in verbal learning and 
working memory [21] in women with a breast cancer diagnosis. There are also improvements 
in working memory, attention and processing speed in childhood survivors of cancer [22]. 
Such improvements have the potential to greatly enhance quality of life in survivors through 
improving cognitive flexibility. 
The hypothesis that improvements in attentional control via engaging cognitive 
training tasks can attenuate negative affect was addressed in a recent systematic review [11] 
and in a meta-analysis [23] of cognitive control training studies, with gains in working 
memory improvements associated with reductions in negative affect. Adaptive cognitive 
training has reduced rumination in clinical depression [24] and anxious symptomatology in 
anxiety [13]. Sari, Koster, Pourtois & Derakshan [13] showed that a 3 week course of 
adaptive dual n-back training, previously shown to increase fluid intelligence [19] and 
processing efficiency in sub-clinically depressed individuals [25], can reduce anxiety in 
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highly anxious individuals. In the adaptive dual n-back training prefrontal functions of 
control are exercised and engaged in a systematic and adaptive manner. Other studies have 
reported increases in resilience in students at risk of depression [26] and reduced symptoms 
of burnout as part of a stress rehabilitation program in exhaustion disorder [27]. Adaptive 
cognitive training can regulate prefrontal – amygdala activity [12], so has the potential to 
modify the emotion-cognition prefrontal network crucial for emotion regulation.  
 
The current investigation 
Adaptive cognitive training holds the promise to help reduce emotional vulnerability 
by enhancing processing efficiency in breast cancer survivorship. Using the ORBIT Model 
[29] for developing behavioral treatments for chronic diseases (see figure b. supplementary 
materials) the current intervention validated the effectiveness of the adaptive dual n-back 
training to translate basic behavioral scientific findings to clinical application. 
In a former feasibility study, which acted as a preliminary/proof of concept study for 
the present investigation (Phase IIa along the ORBIT pathway), we successfully determined 
the efficacy of the adaptive dual n-back cognitive training in improving working memory 
capacity and reducing anxiety related symptomatology in a small group (N = 17) of survivors 
of non-metastatic breast cancer who were recruited from The Breast Cancer Care (UK) 
charity. The current intervention extended these effects on emotional vulnerability in a larger 
sample of women with breast cancer (Phase IIb along the ORBIT pathway), the majority of 
whom had primary non-metastatic breast cancer. We predicted that training related benefits 
would result in reductions in anxiety vulnerability post vs pre-intervention in the adaptive 
training compared with the active control group, with effects sustained at shorter and longer 
follow-up time points. The study received ethical approval from the research ethics 
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committee of the Department of Psychological Sciences at Birkbeck University of London 
(Ref: 141511). Informed consent was obtained from participants prior to participation. 
 
Method 
Participants  
The study was advertised through the Centre for Building Psychological Resilience in 
Breast Cancer on various social media and breast cancer support network platforms using 
Facebook and Twitter. In total, 79 participants (40 Control, 39 Training) were recruited for 
the study. Participants must have had a diagnosis of breast cancer, and be 6 months post 
active treatment to be eligible for participation. All participants received a fee of £100 upon 
testing at one month follow-up, and a £7 Amazon Voucher at the second follow-up.  For 
participant demographics, clinical characteristics and psychiatric history see online 
supplementary materials.  
 
Materials and Experimental Tasks 
Training Tasks: A standard dual n-back task was utilised, replicated from Owens et al., [25]. 
Participants were presented with a 3x3 grid within which a green square appeared at one of 
eight different positions. Concurrently, one of 8 consonants (h, l, c, q, s, r, k and t) were 
presented audibly.  Participants were asked to memorize the position of the green square and 
the letter spoken to them ‘n’ trials back within each trial and respond with appropriate keys 
on the keyboard to indicate a match or a non-match [for further details, see online 
supplementary materials].  
 
Dual N-Back Task (Training):  Participants in the training group completed 20 blocks of 20 
+ n trials per day whereby ‘n’ was determined by the level of n-back that the participant 
7 
 
 7 
reached (e.g. 3-back, 20+3 = 23 trials).  Participants started at the 1-back level for each 
training session. Difficulty level (level of n) was determined by average accuracy percentage 
scores for each block (hit minus false alarm rate) for each modality (auditory and visual). 
When accuracy on both modalities was 95% or above, level of n increased by 1, if less than 
75% it decreased by 1, and if between 75% and 95%, level of n was maintained. Participants 
received feedback on their daily performance.  
   
Dual 1-back Task (Active Control): Participants in the control group undertook a non-
adaptive version of the task whereby the difficulty level remained unchanged. Participants 
began and remained on the 1-back level across 20 blocks per session.  
 
Procedure  
The design followed a pre-intervention, intervention, post-intervention, and two 
follow-ups, the first at one month post intervention and the second at approximately 15 
months (11 – 18 months range) post intervention [see CONSORT diagram in supplementary 
materials]. Allocation to Training or Active Control conditions was achieved using a 
procedure that alternated participants sequentially to either of these conditions.  Participants 
remained naive to the allocation to either the control or training groups and were emailed task 
instructions with verbal instructions over the phone. Participants accessed the task online in 
their homes on a secure and dedicated website, granting access only to the participant and the 
experimenter ensuring confidentiality. They firstly answered demographics questions on their 
breast cancer diagnosis, followed by the first set of questionnaires. They then continued on to 
the training task. Participants completed each daily training session of 30 minutes, across 12 
days, within a two week period, at approximately the same time each day. Performance was 
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monitored by the experimenter daily. On completion of training, participants completed the 
questionnaires, and again at both follow-up time points.   
Outcome Measures 
Primary Outcome: Anxious symptomatology was assessed by a composite score derived 
from the anxious and distress related subscales (Anxious Arousal, General Distress) of the 
Mood and Anxiety Scale Questionnaire (MASQ) [30], a 30-item inventory in which 
frequency of symptoms are indicated on a Likert scale ranging from 1 (‘not at all’) to 5 
(‘extremely’), as well as the anxious subscale (Hyperarousal) of the Cancer Impact of Events 
Scale (IOE) [31] a 22-item inventory, whereby frequency of symptoms are indicated on a 
Likert scale ranging from 0 (‘not at all’) to 4 (‘extremely’). Higher scores indicated higher 
anxiety. The scales demonstrated good reliability in the current study: all Cronbach’s alphas 
>.75.  
Secondary Outcomes: Rumination, a key predictor of depression, was assessed by the 
Ruminative Response Scale [32], a 22-item scale with a Likert scale ranging from 1 (‘almost 
never’ to 4 (‘almost always)’, with higher score indicating higher levels of rumination. 
Depression symptomatology was assessed using the anhedonic depression subscale of the 
MASQ. Worry was assessed by the Penn State Worry Questionnaire [33], measuring trait 
worrying on a Likert scale ranging from 1 (‘not typical of me’) to 5 (‘very typical of me’) 
with higher scores indicating greater pathological worry. Resilience was assessed by the 
Connor Davidson Resilience Scale (CD-RISC) [34], on a Likert scale ranging from 1 (‘not 
true at all’) to 5 (‘true nearly all the time’), with higher scores indicating higher levels of 
resilience. All scales showed good reliability, all Cronbach alphas > .92. 
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Statistical methods 
Data were analysed using IBM SPSS Statistics, Version 22.0. Chi-square tests were 
used to compare group demographics. T-tests were used to assess working memory 
improvement from pre- to post-intervention. 2 (Group: Active Control, Training) X 4 (Time: 
Pre-intervention, Post-intervention, 1
st
 Follow-up, 2
nd
 Follow-up) Linear Mixed Effect 
Models (MLMs) were used to compare groups on self-reported emotional vulnerability 
measures over time. Fixed effects were specified for Group (Active Control, Training), Time 
(Pre-intervention, Post-intervention, 1
st
 Follow-up, 2
nd
 Follow-up), and a Group x Time 
interaction. Data were analysed according to the intention-to-treat (ITT) principle whereby 
the initial sample’s (n = 79) data were analysed, irrespective of whether participants were 
compliant to the entire intervention. Models were estimated with the maximum likelihood 
method. Effect sizes were calculated by Cohen’s d which was derived from the F- test and 
calculated as d = 2*√(F / df). In addition, MLMs were conducted on a per protocol (PP) 
sample which included only the participants who completed the study in its entirety (Control, 
n = 28, Training, n = 32). Post hoc power analysis for the initial sample of 79, and the 
intended MLM analyses with a significance level of 0.05 (alpha), a small to moderate effect 
size of .3d), with three time point measurements (pre, post, and first follow-up) was .83, and 
for the final sample of 60, with four time point measurements (pre, post, first and second 
follow-ups), with the same specifications as above, the desired power was .79. 
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Results 
Dual n-Back Performance 
1-back Control Group: There was a good average level of accuracy across the 12 days of 
training sessions (M = 96.28 %, SD = 7.03). N-back Training Group: Figure 1 shows that 
working memory functioning, as measured by increasing levels of N, improved from Day 1 
(M = 1.49, SD = 7.03) to Day 12 (M = 2.78, SD = .62), t(31) = 14.27, p < .001. The slope of 
this improvement was significantly different from zero t(38) = 8.60, p <.001.  
 
----------------- 
Insert Figure 1 here 
----------------- 
 
Changes in Emotional Vulnerability 
------------------ 
Insert Table 1 here 
----------------- 
 
Mean self-reported symptomatology for each group at each time point is presented in Table 
1.
 1
 The groups did not differ significantly at pre-intervention on any of the measures, all t’s < 
.95, NS.  
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Effects on primary outcome 
Anxiety symptomatology:  
Composite scores were used in order to specifically test the primary outcome of anxiety and 
to protect against the risk of a false positive [35]. These were determined using a factor 
analysis, whereby each subscale (Anxious Arousal, General Distress and Hyperarousal) 
showed consistently high correlations with each other (>.6) across all time points. Figure 2 
shows that participants in the Training group showed marked and sustained reductions in 
anxiety symptomaotology relative to the Control group.
 
The MLM confirmed this 
observation with a significant Group X Time interaction, F(3, 68.43) = 2.81,  p  .04, 
Cohen's d = 0.41, (ITT); F(3, 63.48) = 3.07,  p = .03, Cohen's d = 0.44 (PP).2 
 
----------------- 
Insert Figure 2 here 
----------------- 
Effects on secondary outcomes 
Rumination: Figure 3 shows that the Training group’s scores decrease at follow-up times, 
but the Control group’s scores remain consistent across time. This observation was supported 
by a Group X Time interaction, F(3, 82.51) = 2.81, p = .04, Cohen's d = .39 (ITT); F(3, 
75.54) = 2.82, p = .04, Cohen's d = .39 (PP). Depression symptomatology and Resilience: No 
significant interactions were found, Fs < 1, NS. Worry: There was no significant interaction, 
F(3, 74.48) = 1.21, p = .24, Cohen's d = .25 (ITT); F(3, 64.05) = 1.21, p = .32, Cohen's d = .27 
(PP).   
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----------------- 
Insert Figure 3 here 
----------------- 
 
Further Analyses 
Table a. [supplementary materials] indicates group characteristics on demographic variables 
for the initial sample of 79. Group differences were found for age at diagnosis (Training: M = 
47, SD = 6.43, Control: M = 44, SD = 6.94), t(77) = 2.02, p = .05) and number of participants 
taking psychiatric medication for anxiety and/or depression, Χ2 (1) = 3.93, p = .05 (ITT), 
however these differences were not apparent in the final per protocol sample, (Age at 
diagnosis, Training: M = 47, SD = 6.84, Control: M = 45, SD = 6.54), t(58) = 1.23, p = .22; 
Psychiatric medication, Χ2 (1) = 2.64, p = .1). No significant correlations were found between 
any demographic or medical variables and the slope of the primary and secondary outcome 
measures, (all r’s < .26, all p’s > .06).  
 
Additional responses 
Without elicitation, numerous participants expressed the positive impact of training 
on them. Participants spoke of how they would ‘miss the daily challenge’ and how it had 
prompted them to give the ‘brain a bit more of a workout on a regular basis’ because of the 
‘improvement in my memory’. Others commented that it ‘helped me in a funny way to stay 
concentrated on one thing’, ‘made me feel empowered and confident’, and ‘was just what I 
needed’. Overall, participants enjoyed the training with improvement and completion igniting 
a sense of achievement and empowerment.  
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Discussion 
We investigated how adaptive cognitive training via the dual n-back training, 
previously shown to enhance cognitive efficiency and reduce emotional vulnerability in 
anxiety and depression, compared with an active control training, can help increase cognitive 
flexibility and reduce emotional vulnerability in breast cancer survivorship. As predicted, 
working memory performance improved in the training group pre to post intervention. 
Importantly, training-related benefits resulted in reductions in anxiety-related 
symptomatology as well as in rumination. Critically, these reductions were sustained across 
time to one month follow-up and the longer period of 11 – 18 months follow-up testing 
intervals.  
Transfer related gains on anxiety vulnerability imply a significant beneficial impact of 
training on physiological arousal symptoms such as anger and irritability, and difficulty 
concentrating due to cancer related traumatic experiences. Given the numerous physiological 
long-term side effects associated with breast cancer treatment (e.g., lymphedema, peripheral 
neuropathy, menopausal symptoms as well as fatigue and insomnia [36, 37]) this finding is 
particularly pertinent. Thus through remediating anxiety-related symptoms, there is potential 
for cognitive training to attenuate the distress caused by long term side effects that breast 
cancer survivors experience. These results have implications for better regulation of emotion 
and attenuation of cancer related thoughts, especially fear of recurrence, that frequently 
interrupt daily functioning [38]. 
Significant reductions in rumination in the training compared with the control group 
extend previous findings [20, 23] of reduced ruminative thinking in major depression. 
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Rumination is a key cognitive risk factor for depression [16] that involves top-down 
processes which can benefit from training related gains as a result of brain neuroplasticity. By 
reducing rumination through improved cognitive control capabilities, it is possible to protect 
against depression. Rumination has also been linked to a delay in seeking diagnosis for breast 
cancer symptoms and motivational deficits that inhibit individuals from taking required 
action to solve problems [39]. Our current finding is thus key to this population who must 
remain vigilant for symptoms of recurrence and attend follow up appointments with medical 
practitioners.  
Reductions in negative affective symptomatology in the adaptive training versus 
control group were not only apparent at post intervention, but were sustained at one month as 
well as the longer time follow-up of an average of 15 months (11 – 18 month range) post 
intervention. This finding is of key importance because it shows that not only can adaptive 
training be of immediate benefit to reductions in emotional vulnerability in survivors of 
breast cancer, but through its effects on neuroplasticity can encourage engagement with 
behaviors that can help sustain these effects at longer time periods. This demonstrates that 
attentional control processes remain plastic and can be targeted post treatment and has 
important implications for cognitive health post diagnosis. Given the plethora of evidence on 
treatment induced cognitive decline in breast cancer survivors [7], adaptive cognitive training 
can increase and sustain cognitive efficiency instrumental to cognitive health and 
psychological well-being in breast cancer survivorship.   
Training related gains did not significantly correlate with any demographic variables 
such as age, age at diagnosis or time elapsed since diagnosis suggesting that training is 
beneficial for a wider population, irrespective of particular demographic variables relating to 
both age and breast cancer diagnosis. Having said this, future work should systematically 
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manipulate factors such as age at diagnosis and time since diagnosis to fully explore the 
modulating role of such individual difference variables. 
Participants’ positive responses indicated that they felt psychologically empowered. 
With increases in cognitive efficiency, individuals are better equipped and empowered to 
manage and reduce the impact of intrusive and troublesome anxieties through interventions 
that can pose less risk than current pharmaceutical treatments for psychopathology [40]. 
 
Limitations  
The current study has a number of limitations. Participants were recruited via social media 
platforms and therefore may not be representative of the wider population of breast cancer 
survivors. While such recruitment methods can access large numbers of participants, they do 
not provide data on reasons for refusing participation, and clinical characteristics of the 
sample. Future research should extend the current intervention using a registered RCT that 
fully randomizes group allocation of participants and identifies primary and secondary 
outcome measures of interest as well as including measures of cognitive vulnerability and 
participant demographics such as education. The current study did not measure cognitive 
transfer effects and further research should clarify the specific (cognitive) mechanisms 
underlying these beneficial emotional transfer effects of cognitive training. Finally, future 
research should systematically investigate the benefits of training in women with secondary 
and metastatic breast cancer, given that research in secondary breast cancer is sparse, this 
seems highly pertinent.  
 
Clinical Implications 
Attentional control training is a prosperous new technique targeting specific 
cognitive, behavioural and neural networks that play a crucial role in anxiety, stress and 
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rumination [18]. Improved processing efficiency via adaptive cognitive training and its longer 
term effects in sustaining reduced emotional vulnerability has the potential to increase the 
efficacy of therapies such as CBT and mindfulness that can be available on the NHS in breast 
cancer survivorship. The adaptive dual n-back training was recently shown to increase 
mindfulness meditation effects on reductions in worry over time, through its effects on 
processing efficiency [14]. In a recent Cochrane review of 28 studies [28], group Cognitive 
Behavioural Therapy helped reduce emotional vulnerability in non-metastatic breast cancer. 
CBT and mindfulness meditation effectiveness rely on processing efficiency, and as such the 
adaptive dual n-back can help sustain and enhance their effects if used in combination.    
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Table 1. Mean self-report symptomatology scores for each group (Training and Control) at 
pre, post and follow up time points. 
 
Note. Standard deviations are in parentheses. 
 
 
 
 
 
 
 
 
 Pre-Test   Post-Test   Follow-Up 1   Follow-Up 2  
 Training Control Training Control Training Control Training Control 
 
Rumination 
 
41.46 
 
(11.78) 
 
41.53 
 
(12.07) 
 
40.13 
 
(9.23) 
 
40.64 
 
(11.59) 
 
36.94 
 
(8.54) 
 
40.21 
 
(12.66) 
 
35.72 
 
(9.55) 
 
41.28 
 
(13.51) 
Anxiety 
Symptomatology 
 
 
6.11 
 
(1.88) 
 
6.28 
 
(2.36) 
 
5.09 
 
(1.54) 
 
6.12 
 
(2.64) 
 
5.03 
 
(1.56) 
 
6.1 
 
(2.76) 
 
5.11 
 
(2.05) 
 
6.01 
 
(2.72) 
Depression 
Symptomatology 
 
 
3.19 
 
(.83) 
 
3.41 
 
(.87) 
 
3.05 
 
(.83) 
 
3.26 
 
(.93) 
 
3.12 
 
(.87) 
 
3.33 
 
(.88) 
 
3.0 
 
(.83) 
 
2.64 
 
(.90) 
 
Resilience 
 
68.21 (12.60) 62.71 (18.71) 68.84 (11.83) 63.39 (15.13) 69.38 (13.21) 62.54 (18.22) 66.56 (14.99) 61.96 (18.13) 
Worry 49.0 (16.11) 51.04 (15.19) 46.69 (15.55) 48.14 (13.76) 46.34 (15.37) 50.39 (17.41) 45.91 (16.27) 51.21 (16.27) 
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Footnotes 
1
 Mean emotional vulnerability scores reflect the per protocol population for all tables and 
graphs.  
2
 Analyses on the subscales of intrusion and avoidance (Impact of Events) revealed no 
significant effects (all F’s < 1, NS).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
